Aggarwal @docrota et al. RCT abatacept in IIM - 52 week results. IMACS DOI, FI-2, HAQ-DI, CDASI, TIS, MRC response all numerically better, some statistically significant. There looks like a real effect across all subtypes. @RheumNow #ACR22 Abstr#2237 https://t.co/NdkH8BnSEw https://t.co/l7ufagjniX
Links:
Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Subcutan…
https://acrabstracts.org/abstract/randomized-placebo-controlled-trial-to-evalua…
14-11-2022